Ed Croze

2.6k total citations
49 papers, 2.1k citations indexed

About

Ed Croze is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Ed Croze has authored 49 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 28 papers in Immunology and 12 papers in Molecular Biology. Recurrent topics in Ed Croze's work include Cytokine Signaling Pathways and Interactions (27 papers), interferon and immune responses (18 papers) and Multiple Sclerosis Research Studies (8 papers). Ed Croze is often cited by papers focused on Cytokine Signaling Pathways and Interactions (27 papers), interferon and immune responses (18 papers) and Multiple Sclerosis Research Studies (8 papers). Ed Croze collaborates with scholars based in United States, Netherlands and Canada. Ed Croze's co-authors include Lawrence M. Pfeffer, H. Daniel Perez, Sharlene Velichko, Aruna Murti, Stefan N. Constantinescu, Lawrence Steinman, Jerald E. Mullersman, Rajiv Khanna, Blake T. Aftab and V. Wee Yong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Ed Croze

49 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ed Croze United States 30 1.1k 984 581 372 230 49 2.1k
Enrico Arpaia Canada 12 1.2k 1.1× 789 0.8× 909 1.6× 141 0.4× 170 0.7× 20 2.5k
Harjit Dadi Canada 19 1.6k 1.5× 828 0.8× 868 1.5× 145 0.4× 228 1.0× 44 2.7k
Koh Yamamoto Japan 14 1.3k 1.2× 1.1k 1.1× 629 1.1× 119 0.3× 127 0.6× 32 2.2k
S. Jaharul Haque United States 28 981 0.9× 980 1.0× 1.0k 1.8× 167 0.4× 184 0.8× 58 2.5k
Seijiro Minamoto Japan 17 1.5k 1.4× 1.4k 1.4× 694 1.2× 132 0.4× 196 0.9× 30 2.6k
Katja Pokrovskaja Tamm Sweden 30 606 0.6× 1.0k 1.0× 1.3k 2.2× 296 0.8× 589 2.6× 62 2.4k
Diane Watling United Kingdom 20 1.3k 1.2× 1.5k 1.5× 914 1.6× 126 0.3× 164 0.7× 27 2.6k
Martin S. Staege Germany 23 842 0.8× 669 0.7× 1.4k 2.5× 331 0.9× 148 0.6× 108 2.7k
Loretta Tuosto Italy 30 1.7k 1.6× 447 0.5× 850 1.5× 150 0.4× 193 0.8× 66 2.7k
Tomohisa Baba Japan 26 865 0.8× 756 0.8× 597 1.0× 144 0.4× 111 0.5× 54 1.8k

Countries citing papers authored by Ed Croze

Since Specialization
Citations

This map shows the geographic impact of Ed Croze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ed Croze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ed Croze more than expected).

Fields of papers citing papers by Ed Croze

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ed Croze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ed Croze. The network helps show where Ed Croze may publish in the future.

Co-authorship network of co-authors of Ed Croze

This figure shows the co-authorship network connecting the top 25 collaborators of Ed Croze. A scholar is included among the top collaborators of Ed Croze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ed Croze. Ed Croze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bar‐Or, Amit, Michael P. Pender, Rajiv Khanna, et al.. (2019). Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies. Trends in Molecular Medicine. 26(3). 296–310. 184 indexed citations
2.
Dujmović, Irena, Harald Hegen, Pedro Paz, Ed Croze, & Florian Deisenhammer. (2017). Persistency of Neutralizing Anti-Interferon-β Antibodies in Patients with Multiple Sclerosis Treated with Subcutaneous Interferon-β Depends on Antibody Titers, IgG Subclasses, and Affinity Maturation. Journal of Interferon & Cytokine Research. 37(7). 317–324. 6 indexed citations
3.
Yu, Lijian, Ed Croze, Ken Yamaguchi, et al.. (2014). Induction of a Unique Isoform of the NCOA7 Oxidation Resistance Gene by Interferon β-1b. Journal of Interferon & Cytokine Research. 35(3). 186–199. 33 indexed citations
4.
Hartung, Hans, Lawrence Steinman, Douglas S. Goodin, et al.. (2013). Interleukin 17F Level and Interferon Beta Response in Patients With Multiple Sclerosis. JAMA Neurology. 70(8). 1017–1017. 28 indexed citations
5.
Croze, Ed, Ken Yamaguchi, Volker Knappertz, Anthony T. Reder, & Hugh Salamon. (2012). Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis. The Pharmacogenomics Journal. 13(5). 443–451. 36 indexed citations
6.
Erdmann, Joris I., Giovanni Vitale, Peter M. van Koetsveld, et al.. (2011). Effects of Interferons α/β on the Proliferation of Human Micro- and Macrovascular Endothelial Cells. Journal of Interferon & Cytokine Research. 31(5). 451–458. 14 indexed citations
7.
Croze, Ed. (2010). Differential Gene Expression and Translational Approaches to Identify Biomarkers of Interferon Beta Activity in Multiple Sclerosis. Journal of Interferon & Cytokine Research. 30(10). 743–749. 14 indexed citations
8.
Rani, M.R. Sandhya, et al.. (2009). STAT-Phosphorylation–Independent Induction of Interferon Regulatory Factor-9 by Interferon-β. Journal of Interferon & Cytokine Research. 30(3). 163–170. 11 indexed citations
9.
Bernasconi, Eric, Laurent Favre, Michel H. Maillard, et al.. (2009). Granulocyte-macrophage colony-stimulating factor elicits bone marrow-derived cells that promote efficient colonic mucosal healing. Inflammatory Bowel Diseases. 16(3). 428–441. 65 indexed citations
10.
Reder, Anthony T., Sharlene Velichko, Ken Yamaguchi, et al.. (2008). IFN- β 1b Induces Transient and Variable Gene Expression in Relapsing-Remitting Multiple Sclerosis Patients Independent of Neutralizing Antibodies or Changes in IFN Receptor RNA Expression. Journal of Interferon & Cytokine Research. 28(5). 317–331. 40 indexed citations
11.
Croze, Ed, et al.. (2008). Inhibition of neurosphere proliferation by IFNγ but not IFNβ is coupled to neuronal differentiation. Journal of Neuroimmunology. 206(1-2). 32–38. 29 indexed citations
12.
Gong, Qingqing, Kumar S. Bishnupuri, Qizhi Luo, et al.. (2007). Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis. Inflammatory Bowel Diseases. 14(1). 88–99. 111 indexed citations
13.
Wang, Yixin, Valdeci da Cunha, Jon Vincelette, et al.. (2007). Antiviral and myocyte protective effects of murine interferon-β and -α2in coxsackievirus B3-induced myocarditis and epicarditis in Balb/c mice. American Journal of Physiology-Heart and Circulatory Physiology. 293(1). H69–H76. 49 indexed citations
14.
Velichko, Sharlene, et al.. (2004). Interferon receptor expression regulates the antiproliferative effects of interferons on cancer cells and solid tumors. International Journal of Cancer. 111(1). 32–42. 59 indexed citations
15.
Velichko, Sharlene, et al.. (2002). STAT3 Activation by Type I Interferons Is Dependent on Specific Tyrosines Located in the Cytoplasmic Domain of Interferon Receptor Chain 2c. Journal of Biological Chemistry. 277(38). 35635–35641. 29 indexed citations
16.
Croze, Ed, Anna Usacheva, David M. Asarnow, et al.. (2000). Receptor for Activated C-Kinase (RACK-1), a WD Motif-Containing Protein, Specifically Associates with the Human Type I IFN Receptor. The Journal of Immunology. 165(9). 5127–5132. 45 indexed citations
17.
18.
Yang, Chuanhe, Wei Shi, Aruna Murti, et al.. (1996). Direct Association of STAT3 with the IFNAR-1 Chain of the Human Type I Interferon Receptor. Journal of Biological Chemistry. 271(14). 8057–8061. 115 indexed citations
19.
Pu, Haifeng, et al.. (1995). Reconstitution of a High Affinity Binding Site for Type I Interferons. Journal of Biological Chemistry. 270(44). 26033–26036. 37 indexed citations
20.
Croze, Ed, et al.. (1995). The Use of Zwittergent 3-14 in the Purification of Recombinant Human Interferon-β Ser 17 (Betaseron). Journal of Interferon & Cytokine Research. 15(1). 31–37. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Enrico Arpaia Breakdown of academic impact, for papers by Harjit Dadi Breakdown of academic impact, for papers by Koh Yamamoto Breakdown of academic impact, for papers by S. Jaharul Haque Breakdown of academic impact, for papers by Seijiro Minamoto Breakdown of academic impact, for papers by Katja Pokrovskaja Tamm Breakdown of academic impact, for papers by Diane Watling Breakdown of academic impact, for papers by Martin S. Staege Breakdown of academic impact, for papers by Loretta Tuosto Breakdown of academic impact, for papers by Tomohisa Baba
Rankless by CCL
2026